---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-038220"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2026-05-26T21:20:29+00:00"
generated_at: "2026-05-26T21:22:48.202218+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors

## Summary
- Shareholders approved amendment to 2019 Incentive Award Plan, increasing share reserve by 3.8M shares (58% for, 42% against).
- Amendment to certificate of incorporation approved (17.9M for, 1.4M against) to allow officer exculpation under Delaware law.
- Melinda Brown and Geno Germano elected as Class I directors (14.3M and 14.3M votes for respectively).
- Ratified Deloitte & Touche as independent auditor for FY2026 (22.2M for, 99k against).
- Advisory say-on-pay approved (18.7M for, 613k against).

## SEC filing metadata
- accession: 0001628280-26-038220
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2026-05-26T21:20:29+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/dtil-20260521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-038220
- JSON: https://secwatch.observer/filing/0001628280-26-038220.json
- Plain text: https://secwatch.observer/filing/0001628280-26-038220.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
